IMMUNOHEMATOLOGY

PHARMACY 434

Facilitates the understanding and application of the principles of pharmaceutical genetics, immunology, and biotechnology.

PATH 921

Maximize preparedness for residency by correlating basic science concepts with practical decision-making in clinical transfusion medicine. Tested topics are customized based on the student's specialty interests. Topics include hemostasis, immunology of transfusions, transfusion reactions, red blood cell (RBC) antigens and antibodies, product modifications, lab tests, indications, therapeutic apheresis, blood donation, special patient populations and circumstances such as obstetrics or neonates, and massive transfusion in surgery and trauma.

PATH 922

Learn the basic science principles of common laboratory tests. Apply this knowledge to assignments in which you make clinical judgments and answer common patient questions about lab test interpretations. Customize the curriculum based on your specialty interests.

MEDICINE 935

Exposure to patients in outpatient hematology and oncology clinics and on the inpatient consultation service. Oncology-focused rotation topics include staging and prognosis of different malignancies, basics of chemotherapy classes, and indications for chemotherapy. Hematology content includes the diagnostic approach to clotting disorders, anemia, and/or abnormal blood counts. Different chemotherapy treatments for hematologic malignancy may be included in this course. Independent reading is expected; didactic conferences are site-specific.

PATH 962

Understanding molecular mechanisms of hematologic disease, and developing a foundation in the principles of relevant molecular assays, is critical to providing appropriate patient care. Topics include bases of neoplastic disorders of the hematopoietic and lymphoid systems, how underlying molecular abnormalities contribute to the pathophysiology of these diseases, and the evolving spectrum of molecular and cytogenetic/FISH testing and other ancillary testing (such as flow cytometry), which are often utilized in the work-up of hematopoietic and lymphoid malignancies. Learn about strengths and weaknesses of these technologies, and how pathologists integrate results of molecular testing with the traditional histologic exam to produce accurate diagnoses and drive clinical decision making. Develop an understanding of how knowing the underlying molecular pathology of a hematopoietic or lymphoid malignancy can inform prognosis and guide therapy.